F
K. K. Hameed et al.
Paper
Synthesis
1H NMR (CDCl3, 300 MHz): δ = 9.72 (s, 1 H, N-OH), 7.60 (m, 2 H, Ph),
7.43 (m, 3 H, Ph), 5.84 (m, 2 H, CH=CH), 5.04 (br, 1 H, CH-N), 2.17 (m,
1 H, CH2), 1.98 (m, 2 H, CH2), 1.80 (m, 2 H, CH2), 1.68 (m, 1 H, CH2),
1.59 (br, 1 H, CH2), 1.25 (m, 1 H, CH2).
13C NMR (CDCl3, 75 MHz): δ = 168.4 (C=O), 135.3, 133.8, 131.0, 129.9
(arom), 128.1, 127.7 (CH=CH), 57.8 (CH-N), 31.7, 28.15, 28.1, 26.1
(CH2).
All melting points (mp) are uncorrected. Elemental analyses were
performed on a Carlo Erba NA-1500. 1H and 13C NMR spectra were re-
corded on a 300 MHz spectrometer (solvents specified) referenced to
internal TMS. IR spectra (Nujol mulls) were recorded on a Perkin
Elmer RX-1 spectrophotometer. Column chromatography and TLC:
silica gel H60 and GF254, respectively; eluants: cyclohexane/EtOAc
(9:1) to pure EtOAc; MPLC Biotage Flash Master Personal; eluants: cy-
clohexane/EtOAc (9:1) to pure EtOAc.
Anal. Calcd for C14H17NO2 (231.30): C, 72.70; H, 7.41; N, 6.06. Found:
C, 72.69; H, 7.43; N, 6.05.
N-Hydroxybenzimidoyl chloride (11) and mesitylenecarbonitrile ox-
ide (12) were prepared by reported literature procedures.19 3,5-Di-
phenyl-1,2,4-oxadiazole 4-oxide (16) and 3,5-dimesityl-1,2,4-oxadi-
azole 4-oxide (17) were prepared according to the reported synthe-
ses.12,20 Cycloalkenes 13a–d were purchased from chemical suppliers.
Other reagents and solvents were purchased from chemical suppliers
and used without any further purification.
N-(Cyclooct-2-en-1-yl)-N-hydroxybenzamide (14Ad)
White crystals; yield: 1.29 g (53%); mp 100–103 °C (hexane/benzene).
IR: 3121 (OH), 1672 cm–1 (C=O).
1H NMR (CDCl3, 300 MHz): δ = 9.72 (s, 1 H, N-OH), 7.57 (m, 2 H, Ph),
7.45 (m, 3 H, Ph), 5.75 (m, 2 H, CH=CH), 5.25 (br, 1 H, CH-N), 1.18–
2.18 (m, 10 H, CH2).
Ene Reactions of N-Hydroxybenzimidoyl Chloride (11) with
13C NMR (CDCl3, 75 MHz): δ = 168.3 (C=O), 135.4, 133.8, 129.9, 129.4,
(arom), 128.3, 127.8 (CH=CH), 54.3 (CH-N), 32.8, 28.5, 26.1, 26.0, 23.8
(CH2).
Cycloalkenes 13a–d; General Procedure
To a solution of cycloalkene 13a–d (0.1 mol) in DCM (100 mL) was
added NMO (0.012 mol) and distilled Et3N (0.012 mol). N-Hydroxy-
benzimidoyl chloride (11; 0.01 mol) was then dissolved in DCM (50
mL) and the solution added dropwise to the solution of cycloalkene
with stirring at r.t. and the mixture was stirred for a further 48 h.
Then, the mixture was washed with water (2 × 30 mL) and the organic
phase was dried (anhyd Na2SO4). The solvent was evaporated and the
residue was submitted to chromatographic separation for isolation
and purification of the products.
Anal. Calcd for C15H19NO2 (243.14): C, 73.44; H, 7.81; N, 5.74. Found:
C, 73.45; H, 7.83; N, 5.75.
Ene Reactions of Mesitylenecarbonitrile Oxide (12) with
Cycloalkenes 13a–d; General Procedure
To a solution of cycloalkene 13a–d (0.1 mol) in DCM (100 mL) was
added NMO (0.012 mol). Mesitylenecarbonitrile oxide (12; 0.01 mol)
was then dissolved in DCM (50 mL) and the solution added dropwise
to the cycloalkene solution with stirring at r.t. and stirring was con-
tinued for 48 h. The mixture was washed with water (2 × 30 mL) and
the organic phase was dried (anhyd Na2SO4). The solvent was evapo-
rated and the residue was submitted to chromatographic separation
for isolation and purification of the products.
N-(Cyclopent-2-en-1-yl)-N-hydroxybenzamide (14Aa)
White crystals; yield: 1.42 g (70%); mp 135–136 °C (EtOH).
IR: 2930 (OH), 1652 cm–1 (C=O).
1H NMR (CDCl3, 300 MHz): δ = 9.46 (s, 1 H, N-OH), 7.62 (m, 2 H, Ph),
7.43 (m, 3 H, Ph), 6.02 (m, 1 H, =CH), 5.69 (m, 1 H, =CH), 5.49 (br, 1 H,
CH-N), 2.42 (m, 1 H, H-CH), 2.28 (m, 1 H, HC-H), 2.01 (m, 1 H, H-CH),
1.95 (m, 1 H, HC-H).
N-(Cyclopent-2-en-1-yl)-N-hydroxy-2,4,6-trimethylbenzamide
(14Ba)
13C NMR (CDCl3, 75 MHz): δ = 168.4 (C=O), 135.4, 135.1, 129.9, 129.2
White crystals; yield: 2.41 g (99%); mp 117–119 °C (PE/benzene).
IR: 3062 (OH), 1624 cm–1 (C=O).
1H NMR (CDCl3, 300 MHz): δ = 9.16 [9.46]* (s, 1 H, N-OH), 6.81 [6.90]*
(s, 2 H, Mes), 6.04 [5.93]* (m, 1 H, =CH), 5.66 [5.53]* (m, 1 H, =CH),
4.47 [5.72]* (br, 1 H, CH-N), 2.29 (m, 2 H, CH2), 2.22 [2.24]* (s, 3 H,
CH3), 2.16 [2.19]* (s, 3 H, CH3), 2.14 [2.18]* (s, 3 H, CH3), 1.92 (m, 2 H,
CH2); * minor rotamer.
(arom), 128.1, 127.7 (CH=CH), 66.9 (CH-N), 31.3, 26.0 (CH2).
Anal. Calcd for C12H13NO2 (203.14): C, 70.92; H, 6.45; N, 6.89. Found:
C, 70.93; H, 6.43; N, 6.87.
N-(Cyclohex-2-en-1-yl)-N-hydroxybenzamide (14Ab)
White crystals; yield: 0.92 g (42%); mp 132–134 °C (cyclohex-
ane/benzene).
13C NMR (CDCl3, 75 MHz): δ = 169.6 [164.2]* (C=O), 136.5 [137.6]*,
135.2 [133.4]*, 135.0 [133.3]*, 133.1, 129.0, 128.0, (arom), 127.3,
127.2 (CH=CH), 61.1 [65.5]* (CH-N), 31.1 [31.3]*, 25.6 [26.3]*, 20.6,
18.6 (CH2); * minor rotamer.
IR: 3109 (OH), 1768 cm–1 (C=O).
1H NMR (CDCl3, 300 MHz): δ = 9.51 (s, 1 H, N-OH), 7.61 (m, 2 H, Ph),
7.43 (m, 3 H, Ph), 5.89 (m, 1 H, =CH), 5.60 (m, 1 H, =CH), 4.93 (br, 1 H,
CH-N), 1.97 (m, 1 H, H-CH), 1.81 (m, 3 H, CH2), 1.48–1.67 (m, 2 H,
CH2).
13C NMR (CDCl3, 75 MHz): δ = 168.7 (C=O), 130.7, 129.9, 129.5, 129.2,
128.7, 128.3, 128.1 (arom), 127.7, 127.5 (CH=CH), 53.1 (CH-N), 25.4,
24.0, 20.7 (CH2).
Anal. Calcd for C15H19NO2 (243.32): C, 73.44; H, 7.81; N, 5.71. Found:
C, 73.43; H, 7.83; N, 5.72.
N-(Cyclohex-2-en-1-yl)-N-hydroxy-2,4,6-trimethylbenzamide
(14Bb)
Anal. Calcd for C13H15NO2 (217.27): C, 71.87; H, 6.96; N, 6.45. Found:
C, 71.85; H, 6.97; N, 6.47.
White crystals; yield: 1.30 g (50%); mp 131–133 °C (hexane/benzene).
IR: 3130 (OH), 1654 cm–1 (C=O).
1H NMR (CDCl3, 300 MHz): δ = 9.22 (s, 1 H, N-OH), 6.81 (s, 2 H, Mes),
5.91 (m, 1 H, =CH), 5.55 (m, 1 H, =CH), 5.15 (br, 1 H, CH-N), 2.18 (s, 3
H, CH3), 2.16 (s, 3 H, CH3), 2.13 (s, 3 H, CH3), 1.70–2.07 (m, 6 H, CH2).
N-(Cyclohept-2-en-1-yl)-N-hydroxybenzamide (14Ac)
White crystals; yield: 1.16 g (50%); mp 99–102 °C (benzene).
IR: 3144 (OH), 1678 cm–1 (C=O).
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2018, 50, A–H